Literature DB >> 9246576

Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2.

M Lindahl1, C Tagesson.   

Abstract

The inhibitory effect of the plant flavonoid, rutin, on group I phospholipase A2 (PLA2-I) from porcine pancreas and Naja naja, and on group II phospholipase A2 (PLA2-II) from Vipera russelli and Crotalus atrox was investigated. Rutin efficiently inhibited PLA2-II from both Vipera russelli and Crotalus atrox but was only a weak inhibitor of PLA2-I from porcine pancreas and Naja naja. The lack of strong inhibition of pancreatic PLA2-I was not due to contaminating proteins in the enzyme preparation, since the same weak inhibition was obtained against pancreatic PLA2 purified to homogeneity as judged by two-dimensional gel electrophoresis. Rutin also efficiently inhibited human PLA2-II from synovial fluid but was only a weak inhibitor of human PLA2-I from pancreatic juice, suggesting that rutin is a selective PLA2-I from porcine pancreas. The results obtained indicate that the hydroxyl group in 5-position as well as the double bond and the double-bonded oxygen in the oxane ring are all important for the overall ability of flavonoids to inhibit PLA2 activity, and that the hydroxyl groups in 3'- and 4'- position are required for selective inhibition of PLA2-II.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246576     DOI: 10.1023/a:1027306118026

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

1.  Evaluation of antirheumatic drugs for their effect in vitro on purified human synovial fluid phospholipase A2.

Authors:  L A Marshall; J Bauer; M L Sung; J Y Chang
Journal:  J Rheumatol       Date:  1991-01       Impact factor: 4.666

2.  Hydrogen peroxide stimulates phospholipase A2-mediated arachidonic acid release in cultured intestinal epithelial cells (INT 407).

Authors:  C Gustafson; M Lindahl; C Tagesson
Journal:  Scand J Gastroenterol       Date:  1991-03       Impact factor: 2.423

Review 3.  Effects of flavonoids on immune and inflammatory cell functions.

Authors:  E Middleton; C Kandaswami
Journal:  Biochem Pharmacol       Date:  1992-03-17       Impact factor: 5.858

4.  Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate.

Authors:  G W Wright; C E Ooi; J Weiss; P Elsbach
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

5.  Phospholipase A2 activity in human neutrophils. Stimulation by lipopolysaccharide and possible involvement in priming for an enhanced respiratory burst.

Authors:  J R Forehand; R B Johnston; J S Bomalaski
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

6.  Elevation of serum phospholipase A2 in patients at an intensive care unit.

Authors:  M Kitagawa; T Hayakawa; T Kondo; T Shibata; Y Sakai; H Sobajima; H Ishiguro; M Tanikawa; Y Nakae; S Kameya
Journal:  Int J Pancreatol       Date:  1991 Nov-Dec

Review 7.  Phospholipase A2 and arthritis.

Authors:  J S Bomalaski; M A Clark
Journal:  Arthritis Rheum       Date:  1993-02

8.  The requirement for phospholipase A2 for activation of the assembled NADPH oxidase in human neutrophils.

Authors:  R Dana; H L Malech; R Levy
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

9.  Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action.

Authors:  A A Fawzy; B S Vishwanath; R C Franson
Journal:  Agents Actions       Date:  1988-12

10.  Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock.

Authors:  P Vadas; K Scott; G Smith; I Rajkovic; E Stefanski; B D Schouten; R Singh; W Pruzanski
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

View more
  26 in total

1.  Purification and inhibitory profile of phospholipase A2 inhibitors from Australian elapid sera.

Authors:  P G Hains; K W Broady
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

Review 2.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

3.  Inhibitory Effect of Orientin on Secretory Group IIA Phospholipase A2.

Authors:  Jong-Sup Bae
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

4.  Changes in phenols contents from buckwheat sprouts during growth stage.

Authors:  Masahiro Koyama; Chiho Nakamura; Kozo Nakamura
Journal:  J Food Sci Technol       Date:  2011-02-13       Impact factor: 2.701

5.  sPhospholipase A(2) is inhibited by anthocyanidins.

Authors:  Andrea Dreiseitel; Gabriele Korte; Peter Schreier; Anett Oehme; Sanja Locher; Goeran Hajak; Philipp G Sand
Journal:  J Neural Transm (Vienna)       Date:  2009-08-01       Impact factor: 3.575

6.  Mechanism of inhibition of human secretory phospholipase A2 by flavonoids: rationale for lead design.

Authors:  Jens Lättig; Markus Böhl; Petra Fischer; Sandra Tischer; Claudia Tietböhl; Mario Menschikowski; Herwig O Gutzeit; Peter Metz; M Teresa Pisabarro
Journal:  J Comput Aided Mol Des       Date:  2007-08-15       Impact factor: 3.686

7.  Quercetin modulates activities of Taiwan cobra phospholipase A2 via its effects on membrane structure and membrane-bound mode of phospholipase A2.

Authors:  Yi-Ling Chiou; Shinne-Ren Lin; Wan-Ping Hu; Long-Sen Chang
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

8.  Inhibition of Neurotoxic Secretory Phospholipases A(2) Enzymatic, Edematogenic, and Myotoxic Activities by Harpalycin 2, an Isoflavone Isolated from Harpalyce brasiliana Benth.

Authors:  Rafael M Ximenes; Marcelo M Rabello; Renata M Araújo; Edilberto R Silveira; Fábio H R Fagundes; Eduardo B S Diz-Filho; Simone C Buzzo; Veronica C G Soares; Daniela de O Toyama; Henrique H Gaeta; Marcelo Z Hernandes; Helena S A Monteiro; Marcos H Toyama
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-31       Impact factor: 2.629

9.  Therapeutic application of natural inhibitors against snake venom phospholipase A(2).

Authors:  Ramar Perumal Samy; Ponnampalam Gopalakrishnakone; Vincent Tk Chow
Journal:  Bioinformation       Date:  2012-01-06

10.  Harpalycin 2 inhibits the enzymatic and platelet aggregation activities of PrTX-III, a D49 phospholipase A2 from Bothrops pirajai venom.

Authors:  Rafael M Ximenes; Renata S Alves; Ticiana P Pereira; Renata M Araújo; Edilberto R Silveira; Marcelo M Rabello; Marcelo Z Hernandes; Veronica C G Soares; Daniel Bristot; Camila L Pires; Daniela O Toyama; Henrique H Gaeta; Helena S A Monteiro; Marcos H Toyama
Journal:  BMC Complement Altern Med       Date:  2012-08-27       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.